Literature DB >> 24569360

Anticoagulation therapy: Apixaban is cost-effective.

Gregory B Lim.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24569360     DOI： 10.1038/nrcardio.2014.18

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  1 in total

1.  Cost-effectiveness of apixaban vs. current standard of care for stroke prevention in patients with atrial fibrillation.

Authors:  Paul Dorian; Thitima Kongnakorn; Hemant Phatak; Dale A Rublee; Andreas Kuznik; Tereza Lanitis; Larry Z Liu; Uchenna Iloeje; Luis Hernandez; Gregory Y H Lip
Journal:  Eur Heart J       Date:  2014-02-09       Impact factor: 29.983
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.